Clinical Research in Cardiology

, Volume 109, Issue 1, pp 46–53 | Cite as

Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge® Registry

  • Maryna Masyuk
  • Peter Abel
  • Martin Hug
  • Bernhard Wernly
  • Assad Haneya
  • Stefan Sack
  • Konstantinos Sideris
  • Nicolas Langwieser
  • Tobias Graf
  • Georg Fuernau
  • Marcus Franz
  • Ralf Westenfeld
  • Malte Kelm
  • Stephan B. Felix
  • Christian JungEmail author
Original Paper



The concept of percutaneous extracorporeal life support (ECLS) is based on immediate cardiovascular stabilization allowing for sufficient end-organ perfusion, thus improving the outcome in patients with circulatory arrest. Lifebridge® (Zoll Medical GmbH, Germany) is a portable ECLS device designed for rapid application due to its automated set-up.


A total of 60 tertiary cardiovascular centers were interrogated with regard to application and short-term results after use of Lifebridge ECLS system. Detailed data were collected by standardized case report forms in all centers consented to participate in the study. Demographic and clinical baseline characteristics of the patient population, procedural and follow-up data were recorded and analyzed.


In total, 444 patients were analyzed regarding mortality. The detailed study cohort consisted of 112 patients. A total of 80% of the study subjects represented patients post cardiopulmonary resuscitation, 43% were in cardiogenic shock and 50% suffered from acute myocardial infarction. The survival rates were 36% immediately after device implementation and 16% after 30 days. Multivariable analysis revealed that only serum lactate concentration at admission could be proven as independent predictor of patients’ outcome. Patients with lactate concentrations above 10 mmol/L exhibited > 95% mortality (p < 0.05 versus below 10 mmol/L).


The present study provides real-world clinical data of patients treated with a transportable automated ECLS system. In conclusion, Lifebridge is a safely applicable cardiorespiratory stabilization tool associated with acceptable complication rates. Nevertheless, mortality rates were high in these critically ill patients, especially in those showing high lactate concentrations at admission.


Cardiogenic shock Mechanical circulatory support Extracorporeal life support ECLS Cardiac arrest 


  1. 1.
    Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J (2009) Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 119:1211–1219. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634. CrossRefPubMedGoogle Scholar
  3. 3.
    Stretch R, Sauer CM, Yuh DD, Bonde P (2014) National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis. J Am Coll Cardiol 64:1407–1415. CrossRefGoogle Scholar
  4. 4.
    Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, Buerke U, Raaz U, Ebelt H, Schlitt A, Heinroth K, Haerting J, Werdan K, Buerke M (2012) Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardiale infarction complicated by cardiogenetic shock: the prospective, randomized IABP shock trial. Shock Inj Inflamm Sepsis Lab Clin Approaches 37:378–384. CrossRefGoogle Scholar
  5. 5.
    Sjauw KD, Engström AE, Vis MM, van der Schaaf RJ, Baan J, Koch KT, de Winter RJ, Piek JJ, Tijssen JGP, Henriques JPS (2009) A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 30:459–468. CrossRefPubMedGoogle Scholar
  6. 6.
    Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382:1638–1645. CrossRefPubMedGoogle Scholar
  7. 7.
    Thiele H, Zeymer U, Neumann F-J, Ferenc M, Olbrich H-G, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Böhm M, Ebelt H, Schneider S, Schuler G, Werdan K (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367:1287–1296. CrossRefPubMedGoogle Scholar
  8. 8.
    Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39:119–177. CrossRefGoogle Scholar
  9. 9.
    Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, Agrawal S, Arora S, Patel N, Wald J, Jorde UP (2018) Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107:287–303. CrossRefPubMedGoogle Scholar
  10. 10.
    Backhaus T, Fach A, Schmucker J, Fiehn E, Garstka D, Stehmeier J, Hambrecht R, Wienbergen H (2018) Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry. Clin Res Cardiol 107:371–379. CrossRefPubMedGoogle Scholar
  11. 11.
    Thiele H, Smalling RW, Schuler GC (2007) Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 28:2057–2063. CrossRefPubMedGoogle Scholar
  12. 12.
    Jung C, Janssen K, Kaluza M, Fuernau G, Poerner TC, Fritzenwanger M, Pfeifer R, Thiele H, Figulla HR (2016) Outcome predictors in cardiopulmonary resuscitation facilitated by extracorporeal membrane oxygenation. Clin Res Cardiol 105:196–205. CrossRefPubMedGoogle Scholar
  13. 13.
    Chen Y-S, Lin J-W, Yu H-Y, Ko W-J, Jerng J-S, Chang W-T, Chen W-J, Huang S-C, Chi N-H, Wang C-H, Chen L-C, Tsai P-R, Wang S-S, Hwang J-J, Lin F-Y (2008) Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet 372:554–561. CrossRefPubMedGoogle Scholar
  14. 14.
    Jung C, Schlosser M, Figulla H-R, Ferrari M (2009) Providing macro- and microcirculatory support with the Lifebridge System during high-risk PCI in cardiogenic shock. Heart Lung Circ 18:296–298. CrossRefPubMedGoogle Scholar
  15. 15.
    Jung C, Franz M, Figulla H-R, Sonntag S, Hug M, Mudra H, Bauerschmitt R, Kleber F-X, Feindt P, Mehlhorn U, Vahl C, Bruns H-J, Ferrari M (2015) Percutaneous extracorporeal life support in patients with circulatory failure: results of the German Lifebridge Registry. J Invasive Cardiol 27:93–97PubMedGoogle Scholar
  16. 16.
    Paden ML, Conrad SA, Rycus PT, Thiagarajan RR (2013) Extracorporeal life support organization registry report 2012. ASAIO J 59:202–210. CrossRefPubMedGoogle Scholar
  17. 17.
    Rogers JG, O’Connor CM (2014) The changing landscape of advanced heart failure therapeutics. J Am Coll Cardiol 64:1416–1417. CrossRefPubMedGoogle Scholar
  18. 18.
    Ouweneel DM, Schotborgh JV, Limpens J, Sjauw KD, Engström AE, Lagrand WK, Cherpanath TGV, Driessen AHG, de Mol BAJM, Henriques JPS (2016) Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 42:1922–1934. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ouweneel DM, Henriques JPS (2012) Percutaneous cardiac support devices for cardiogenic shock: current indications and recommendations. Heart 98:1246–1254. CrossRefPubMedGoogle Scholar
  20. 20.
    Werdan K, Gielen S, Ebelt H, Hochman JS (2014) Mechanical circulatory support in cardiogenic shock. Eur Heart J 35:156–167. CrossRefPubMedGoogle Scholar
  21. 21.
    de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H (2016) Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. EuroIntervention 11:1363–1371. CrossRefPubMedGoogle Scholar
  22. 22.
    Dzavik V, Sleeper LA, Cocke TP, Moscucci M, Saucedo J, Hosat S, Jiang X, Slater J, LeJemtel T, Hochman JS (2003) Early revascularization is associated with improved survival in elderly patients with acute myocardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J 24:828–837CrossRefGoogle Scholar
  23. 23.
    de Waha S, Graf T, Desch S, Fuernau G, Eitel I, Pöss J, Jobs A, Stiermaier T, Ledwoch J, Wiedau A, Lurz P, Schuler G, Thiele H (2017) Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock. Clin Res Cardiol 106:379–385. CrossRefPubMedGoogle Scholar
  24. 24.
    Parissis H, Soo A, Al-Alao B (2011) Intra aortic balloon pump: literature review of risk factors related to complications of the intraaortic balloon pump. J Cardiothorac Surg 6:147. CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Vellinga NAR, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, Pearse RM, van der Voort PHJ, Dondorp AM, Bafi T, Fries M, Akarsu-Ayazoglu T, Pranskunas A, Hollenberg S, Balestra G, van Iterson M, Sadaka F, Minto G, Aypar U, Hurtado FJ, Martinelli G, Payen D, van Haren F, Holley A, Gomez H, Mehta RL, Rodriguez AH, Ruiz C, Canales HS, Duranteau J, Spronk PE, Jhanji S, Hubble S, Chierego M, Jung C, Martin D, Sorbara C, Bakker J, Ince C (2017) Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis. Crit Care 21:255. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Vink EE, Bakker J (2018) Practical use of lactate levels in the intensive care. J Intensive Care Med 33:159–165. CrossRefPubMedGoogle Scholar
  27. 27.
    Kiyatkin ME, Bakker J (2017) Lactate and microcirculation as suitable targets for hemodynamic optimization in resuscitation of circulatory shock. Curr Opin Crit Care 23:348–354. CrossRefPubMedGoogle Scholar
  28. 28.
    Masyuk M, Wernly B, Lichtenauer M, Franz M, Kabisch B, Muessig JM, Zimmermann G, Lauten A, Schulze PC, Hoppe UC, Kelm M, Bakker J, Jung C (2019) Prognostic relevance of serum lactate kinetics in critically ill patients. Intensive Care Med 45:55–61. CrossRefPubMedGoogle Scholar
  29. 29.
    Jung C, Bueter S, Wernly B, Masyuk M, Saeed D, Albert A, Fuernau G, Kelm M, Westenfeld R (2019) Lactate clearance predicts good neurological outcomes in cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation. J Clin Med. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    O’Neill WW, Kleiman NS, Moses J, Henriques JPS, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M (2012) A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation 126:1717–1727. CrossRefPubMedGoogle Scholar
  31. 31.
    Thiele H, Allam B, Chatellier G, Schuler G, Lafont A (2010) Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J 31:1828–1835. CrossRefPubMedGoogle Scholar
  32. 32.
    Becher PM, Schrage B, Sinning CR, Schmack B, Fluschnik N, Schwarzl M, Waldeyer C, Lindner D, Seiffert M, Neumann JT, Bernhardt AM, Zeymer U, Thiele H, Reichenspurner H, Blankenberg S, Twerenbold R, Westermann D (2018) Venoarterial extracorporeal membrane oxygenation for cardiopulmonary support. Circulation 138:2298–2300. CrossRefPubMedGoogle Scholar
  33. 33.
    Donker DW, Brodie D, Henriques JPS, Broomé M (2019) Left ventricular unloading during veno-arterial ECMO: a review of percutaneous and surgical unloading interventions. Perfusion 34:98–105. CrossRefPubMedGoogle Scholar
  34. 34.
    Schrage B, Burkhoff D, Rübsamen N, Becher PM, Schwarzl M, Bernhardt A, Grahn H, Lubos E, Söffker G, Clemmensen P, Reichenspurner H, Blankenberg S, Westermann D (2018) Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock. JACC Heart Fail 6:1035–1043. CrossRefPubMedGoogle Scholar
  35. 35.
    Lee JS, Roberts SWP, Götsch K, Moeller U, Hawryluck L (2019) Caring for critically ill patients in humanitarian settings. Am J Respir Crit Care Med 199:572–580. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Maryna Masyuk
    • 1
  • Peter Abel
    • 2
  • Martin Hug
    • 3
  • Bernhard Wernly
    • 4
  • Assad Haneya
    • 5
  • Stefan Sack
    • 6
  • Konstantinos Sideris
    • 7
  • Nicolas Langwieser
    • 8
  • Tobias Graf
    • 9
  • Georg Fuernau
    • 9
  • Marcus Franz
    • 10
  • Ralf Westenfeld
    • 1
  • Malte Kelm
    • 1
    • 11
  • Stephan B. Felix
    • 2
    • 12
  • Christian Jung
    • 1
    Email author
  1. 1.Division of Cardiology, Pulmonary Diseases and Vascular Medicine, Department of MedicineUniversity Hospital DüsseldorfDüsseldorfGermany
  2. 2.Division of Cardiology, Pneumology and Critical Care Medicine, Department of Internal Medicine BUniversity Medicine GreifswaldGreifswaldGermany
  3. 3.Department of Cardiology, Pulmonology and Internal Intensive Care MedicineStädtisches Klinikum München GmbH, Klinikum NeuperlachMunichGermany
  4. 4.Department of CardiologyParacelsus Medical UniversitySalzburgAustria
  5. 5.Department of Cardiovascular SurgeryUniversity of SchleswigKielGermany
  6. 6.Department of Cardiology, Pneumology, and Internal Intensive Care Medicine, Schwabing HospitalAcademic Municipal Hospital MunichMunichGermany
  7. 7.Department of Cardiovascular Surgery, German Heart CenterTechnische Universität München (TUM)MunichGermany
  8. 8.Medical Clinic I, Klinikum rechts der IsarTechnical University of MunichMunichGermany
  9. 9.Department of Cardiology, Angiology, Intensive Care Medicine, Medical Clinic IIUniversity Heart Center LübeckLübeckGermany
  10. 10.Department of Cardiology, Clinic of Internal Medicine I, Jena University HospitalFriedrich Schiller University JenaJenaGermany
  11. 11.CARID: Cardiovascular Research Institute DüsseldorfDüsseldorfGermany
  12. 12.DZHK (German Center for Cardiovascular Research), Partner Site GreifswaldGreifswaldGermany

Personalised recommendations